Voloridge Investment Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
+633,204
| New | +$20.6M | 0.08% | 314 |
|
|
2024
Q4 | – | Sell |
-224,446
| Closed | -$25.6M | – | 1323 |
|
|
2024
Q3 | $25.6M | Buy |
+224,446
| New | +$25.6M | 0.09% | 315 |
|
|
2023
Q3 | – | Sell |
-40,764
| Closed | -$2.04M | – | 1552 |
|
|
2023
Q2 | $2.04M | Sell |
40,764
-194,817
| -83% | -$9.73M | 0.01% | 980 |
|
|
2023
Q1 | $8.83M | Sell |
235,581
-15,605
| -6% | -$585K | 0.04% | 483 |
|
|
2022
Q4 | $12M | Buy |
+251,186
| New | +$12M | 0.07% | 383 |
|
|
2022
Q3 | – | Sell |
-12,475
| Closed | -$271K | – | 1575 |
|
|
2022
Q2 | $271K | Buy |
+12,475
| New | +$271K | ﹤0.01% | 1358 |
|
|
2021
Q3 | – | Sell |
-70,341
| Closed | -$1.58M | – | 1807 |
|
|
2021
Q2 | $1.58M | Buy |
70,341
+21,095
| +43% | +$475K | 0.01% | 1079 |
|
|
2021
Q1 | $973K | Buy |
+49,246
| New | +$973K | 0.01% | 1026 |
|